Cancer

Study investigates treatment regret among prostate cancer survivors

Charlie Schmidt
Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease

Surveys of over 900 men who were diagnosed with prostate cancer in the 1990s found that approximately 15% had some regret over their treatment choices. Study authors encourage doctors and patients to have frank and thorough discussions about about the risks and benefits of various forms of treatment for prostate cancer.

Time to rethink the debate on PSA testing

Steven J. Atlas, MD, MPH

The debate about PSA screening for prostate cancer has been going on for decades, and research has been similarly divided. For most men, the best advice is to talk with your doctor so the benefits and risks of the test are clear.

Combination hormonal therapy boosts survival in men with aggressive prostate cancer

Charlie Schmidt
Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease

The results of two studies found that using the drug abiraterone in combination with other hormonal therapy drugs to treat aggressive prostate cancer produced more favorable results than the first-line therapy alone.

Yoga improves treatment-related symptoms in men with prostate cancer

Charlie Schmidt
Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease

Men who participated in yoga classes twice a week while being treated for prostate cancer reported less fatigue and better urinary and erectile function, compared to other men in the study who did not do yoga.

This just in: Exercise is good for you

Robert H. Shmerling, MD
Robert H. Shmerling, MD, Faculty Editor, Harvard Health Publications

If you are trying to follow the recommended guidelines for physical activity, the best way to spend your time may be running, but a study of commuters found that those who walked or bicycled to work also had lower rates of heart disease and cancer.

Shopping for sunscreen: Are all brands equal?

Emily S. Ruiz, MD, MPH
Emily S. Ruiz, MD, MPH, Contributor

The variety of sunscreens available can be confusing to consumers who want to know they are choosing a product that offers appropriate protection from harmful ultraviolet rays. New sunscreen ingredients currently in use in Europe are still in the pipeline waiting FDA approval in the US.

Combining surgery, radiation, and hormonal therapy dramatically extends survival in men with advanced prostate cancer

Charlie Schmidt
Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease

A small pilot study that combined surgery, radiation, and hormone therapy may lead to future treatment options for men with prostate cancer that has spread beyond the gland.

Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer

Charlie Schmidt
Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease

For men who have had prostate gland removal surgery, results from a new study show that a combination of radiation treatment and androgen deprivation therapy is more effective for treating PSA recurrence than radiation alone.

To PSA test or not to PSA test: That is the discussion

Steven J. Atlas, MD, MPH

The recommended guidelines for whether men should have the prostate cancer screening test have changed in recent years. A man considering the test should talk with his doctor and understand all the pros and cons involved.

The problem with tanning (and the myth of the base tan)

Robert H. Shmerling, MD
Robert H. Shmerling, MD, Faculty Editor, Harvard Health Publications

The earlier one starts tanning, the longer the lifetime skin damage and the higher the skin cancer risk. As the number of people with skin cancer increases, it has become especially important to convey to teenagers the message that tanning is an unhealthy choice, whether it’s outdoors or in a tanning bed.